S
Salvatore Brugaletta
Researcher at University of Barcelona
Publications - 393
Citations - 9512
Salvatore Brugaletta is an academic researcher from University of Barcelona. The author has contributed to research in topics: Myocardial infarction & Stent. The author has an hindex of 42, co-authored 338 publications receiving 7967 citations. Previous affiliations of Salvatore Brugaletta include The Catholic University of America & Cardiovascular Institute of the South.
Papers
More filters
Journal ArticleDOI
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
Marco Valgimigli,Andrea Gagnor,Paolo Calabrò,Enrico Frigoli,Sergio Leonardi,Tiziana Zaro,Paolo Rubartelli,Carlo Briguori,Giuseppe Andò,Alessandra Repetto,Ugo Limbruno,Bernardo Cortese,Paolo Sganzerla,Alessandro Lupi,Mario Galli,Salvatore Colangelo,Salvatore Ierna,Arturo Ausiello,Patrizia Presbitero,Gennaro Sardella,Ferdinando Varbella,Giovanni Esposito,Andrea Santarelli,Simone Tresoldi,Marco Stefano Nazzaro,Antonio Zingarelli,Nicoletta De Cesare,Stefano Rigattieri,Paolo Tosi,Cataldo Palmieri,Salvatore Brugaletta,Sunil V. Rao,Dik Heg,Martina Rothenbühler,Pascal Vranckx,Peter Jüni +35 more
TL;DR: In patients with acute coronary syndrome undergoing invasive management, radial as compared with femoral access reduces net adverse clinical events, through a reduction in major bleeding and all-cause mortality.
Journal ArticleDOI
Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI
Justin E. Davies,Sayan Sen,Hakim-Moulay Dehbi,Hakim-Moulay Dehbi,Hakim-Moulay Dehbi,Rasha Al-Lamee,Ricardo Petraco,Sukhjinder Nijjer,Ravinay Bhindi,Sam J. Lehman,Darren L. Walters,James Sapontis,Luc Janssens,Christiaan J. Vrints,Ahmed Khashaba,Mika Laine,E. Van Belle,Florian Krackhardt,Waldemar Bojara,Olaf Going,Tobias Härle,Ciro Indolfi,Giampaolo Niccoli,Flavo Ribichini,Nobuhiro Tanaka,Hiroyoshi Yokoi,Hiroaki Takashima,Yuetsu Kikuta,Andrejs Erglis,Hugo Vinhas,P. Canas Silva,Sérgio Bravo Baptista,Ali Alghamdi,Farrel Hellig,Bon Kwon Koo,Chang Wook Nam,Eun-Seok Shin,Joon Hyung Doh,Salvatore Brugaletta,Eduardo Alegría-Barrero,Martijn Meuwissen,Jan J. Piek,N. van Royen,Murat Sezer,C. Di Mario,Robert Gerber,Iqbal S. Malik,Andrew S.P. Sharp,Suneel Talwar,Kare Tang,Habib Samady,John D. Altman,Arnold H. Seto,J. Singh,Allen Jeremias,Hitoshi Matsuo,Rajesh K. Kharbanda,Manesh R. Patel,P. Serruys,Javier Escaned,Javier Escaned +60 more
TL;DR: Coronary revascularization guided by iFR was noninferior to revascularizations guided by FFR with respect to the risk of major adverse cardiac events at 1 year.
Journal ArticleDOI
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
Manel Sabaté,Angel Cequier,Andrés Iñiguez,Antonio Serra,Rosana Hernández-Antolín,Vicente Mainar,Marco Valgimigli,Maurizio Tespili,Pieter den Heijer,Armando Bethencourt,Nicolás Vázquez,Joan Antoni Gómez-Hospital,José Antonio Baz,Victoria Martin-Yuste,Robert-Jan van Geuns,Fernando Alfonso,Pascual Bordes,Matteo Tebaldi,Mónica Masotti,Antonio Silvestro,Bianca Backx,Salvatore Brugaletta,Gerrit Anne van Es,Patrick W. Serruys +23 more
TL;DR: The 1-year result of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) trial, comparing EES with bare-metal stents (BMS) in patients with STEMI, is reported, which shows device success rate was similar between groups, but procedure success rates were significantly higher in the EES group.
Journal ArticleDOI
Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial
Olivier Varenne,Stéphane Cook,Georgios Sideris,Sasko Kedev,Thomas Cuisset,Didier Carrié,Thomas Hovasse,Philippe Garot,Rami El Mahmoud,Christian Spaulding,Gérard Helft,José Francisco Díaz Fernández,Salvatore Brugaletta,Eduardo Pinar-Bermudez,Josepa Mauri Ferre,Philippe Commeau,Emmanuel Teiger,Kris Bogaerts,Kris Bogaerts,Manel Sabaté,Marie-Claude Morice,Peter Sinnaeve +21 more
TL;DR: Among elderly patients who have PCI, a DES and a short duration of DAPT are better than BMS and a similar duration ofDAPT with respect to the occurrence of all-cause mortality, myocardial infarction, stroke, and ischaemia-driven target lesion revascularisation.
Journal ArticleDOI
Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents.
Soji Nishio,Kunihiko Kosuga,Keiji Igaki,Masaharu Okada,Eisho Kyo,Takafumi Tsuji,Eiji Takeuchi,Yasutaka Inuzuka,Shinsaku Takeda,Tatsuhiko Hata,Yuzo Takeuchi,Yoshitaka Kawada,Takeshi Harita,Junya Seki,Shunji Akamatsu,Shinichi Hasegawa,Nico Bruining,Salvatore Brugaletta,Sebastiaan de Winter,Takashi Muramatsu,Yoshinobu Onuma,Patrick W. Serruys,Shigeru Ikeguchi +22 more
TL;DR: In this paper, the authors evaluated the long-term safety of the Igaki-Tamai stent, the first-in-human fully biodegradable coronary stent made of poly-l-lactic acid.